Evidence map›Paper›PMID 34690635›Full record

ArticleEngineering in life sciences2021

Simultaneous solid-liquid separation and primary purification of clavulanic acid from fermentation broth of

Xu-Dong Wang, Chun-Yan Hu, Chao Qin, Yue-Sheng Dong, Guo-Qing Ying, Zhi-Long Xiu, Zhi-Guo Su

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Engineering in life sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Xu-Dong WangSchool of Bioengineering Dalian University of Technology Dalian P. R. China.
Chun-Yan HuSchool of Bioengineering Dalian University of Technology Dalian P. R. China.
Chao QinSchool of Bioengineering Dalian University of Technology Dalian P. R. China.
Yue-Sheng DongSchool of Bioengineering Dalian University of Technology Dalian P. R. China.
Guo-Qing YingCollege of Pharmaceutical Science Zhejiang University of Technology Hangzhou P. R. China.
Zhi-Long XiuSchool of Bioengineering Dalian University of Technology Dalian P. R. China.ORCID https://orcid.org/0000-0003-4350-0059
Zhi-Guo SuState Key Laboratory of Biochemical Engineering Institute of Process Engineering Chinese Academy of Sciences Beijing P. R. China.
Dalian University of Technology · CNChinese Academy of Sciences · CNZhejiang University of Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clavulanic acid (CA) is usually used together with other β-lactam antibiotics as combination drugs to inhibit bacterial β-lactamases, which is mainly produced from the fermentation of microorganism such as

Indexed as

clavulanic acidfermentation brothsalting‐out extractionsolid–liquid separation

Identifiers

PMID34690635
PMCPMC8518655
OpenAlexW3189561153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.